HI All have just checked out the webcast on Isis from the meeting of shareholders well worth a look the points I make below are taken from this webcast slide 8 ANP shown slide 14 Key principles antisense technology works slide 16 broadly speaking pipeline drugs work slide 18 Kynamaro(mipomersen) the EU have said the info that has been provided should be sufficient for the approval to treat hoFH and heFH NDA looking to only approve this drug for hoFH to start and will approve maybe broader range of applications at later point slide 21 isis has demonstarted that antisense works due to robust efficiacy and safety profile, slide 79 ATL1103 mentioned and shown slide 85 unequivical proof was stated, so this is what I have taken from this webcast. Well worth a look webcast available for limited time maybe another day well worth a look and a ponder over the long weekend makes one somewhat "excited" all my opinion information provide taken from isis webcast from the website
ANP Price at posting:
18.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)